- we maintain a broad portfolio, with a particular interest in respiratory disease, infections and antibiotic resistance, liver disease, cardiovascular disease, primary care and herbal treatments
- we can develop and conduct a broad range of trials, from drug trials and complex interventions, through to symptom control and digital technologies
- we are closely linked with the NIHR Southampton Biomedical Research Centre, where our Director is a co-investigator on the respiratory theme
- our team has expertise in trial methodology and qualitative research with the aim of improving trial design and research outcomes for the research community, trial participants and healthcare providers
Our statisticians are at the forefront of innovative trial development, such as the use of adaptive Bayesian designs for phase I dose-finding studies, as used in the AGILE COVID-19 platform.